Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Genedrive Share Price
  4. Genedrive Share Regulatory News
  5. Additional Listing

Pin to quick picksGenedrive Regulatory News (GDR)

Genedrive Information

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.275    0.025 (2.04%)
Bid:
1.20
Ask:
1.35
Spread: 0.15 (12.50%)
Market Cap: £20.07m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Additional Listing

1 May 2014 16:37

RNS Number : 1150G
Epistem Holdings plc
01 May 2014
Β 

ο»Ώ

Β 

Β 

Epistem Holdings Plc

Additional Listing

Epistem (AIM: EHP) announces thatΒ 239,666Β new ordinary shares of 1.5 pence each (theΒ "New Ordinary Shares") have been issued and allottedΒ pursuant to the exercise of options under the Epistem Holdings Plc EMI Share Option Scheme.

Application has been madeΒ to the London Stock ExchangeΒ for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to be effective on 8th May, 2014 and, when issued, the New Ordinary Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Following the admission to trading of theΒ New Ordinary Shares, Epistem will haveΒ 10,004,906Β ordinary shares of 1.5 pence each in issue.

Β 

Β 

For further details please contact:

Β 

Epistem Plc

Matthew Walls, CEO +44 161 606 7258

John Rylands, Finance Director +44 161 606 7244

Β 

Peel Hunt LLP

James Steel +44 20 7418 8900

Clare Terlouw

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
LISUGUPWAUPCGAG
12345678910
Date   Source Headline
17th Jun 20244:41 pmRNSHolding(s) in Company
13th Jun 20243:22 pmRNSHolding(s) in Company
11th Jun 202412:54 pmRNSHolding(s) in Company
7th Jun 202411:00 amRNSHolding(s) in Company
5th Jun 20243:45 pmRNSHolding(s) in Company
5th Jun 202411:39 amRNSHolding(s) in Company
31st May 20243:56 pmRNSBlock listing returns
31st May 202411:24 amRNSResult of General Meeting
30th May 20247:00 amRNSResult of Open Offer and REX Offer
24th May 20247:00 amRNSInitial orders of the Genedrive MT-RNR1 Products
21st May 202411:00 amRNSKey CYP2C19-ID test performance milestone achieved
15th May 20247:00 amRNSAmendment to Open Offer timetable
14th May 20247:00 amRNSPublication of Circular and Notice of GM
10th May 20247:00 amRNSCompletion of placing
9th May 20244:49 pmRNSProposed REX Retail Offer
9th May 20244:48 pmRNSProposed Fundraise for a minimum of £6.0 million
24th Apr 20243:36 pmRNSClinical Trial Agreement
3rd Apr 20245:00 pmRNSApplication for Listing & Total Voting Rights
3rd Apr 20247:00 amRNSNICE recommends the Genedrive CYP2C19-ID Kit
28th Mar 20247:00 amRNSHalf-year Report
26th Mar 20247:00 amRNSInvestor presentation
19th Mar 20243:53 pmRNSApplication for Listing & Total Voting Rights
15th Mar 202412:30 pmRNSReceipt of R&D tax credit
19th Feb 20247:00 amRNSNICE Early Value Assessment update
6th Feb 20242:03 pmRNSDirector/PDMR Shareholding
2nd Feb 20243:35 pmRNSTotal Voting Rights
19th Jan 20244:14 pmRNSTotal Voting Rights
15th Jan 20243:21 pmRNSTotal Voting Rights
10th Jan 20247:00 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSEquity Prepayment Facility drawdown
29th Dec 202311:44 amRNSResult of AGM
20th Dec 20234:57 pmRNSTotal Voting Rights
20th Dec 20237:00 amRNSInitial overseas orders of MT-RNR1 ID kit
7th Dec 20237:00 amRNSTotal Voting Rights
6th Dec 20237:00 amRNSPosting of annual report and notice of AGM
6th Dec 20237:00 amRNSTotal Voting Rights
4th Dec 20231:13 pmRNSMT-RNR1 ID kit adopted for routine use in Brighton
30th Nov 20235:29 pmRNSBlock listing Interim Review
30th Nov 20237:00 amRNSFinal Results
29th Nov 20235:25 pmRNSEquity Prepayment Facility drawdown
16th Nov 20237:00 amRNSNotice of Results
20th Oct 202310:52 amRNSTotal Voting Rights
28th Sep 202312:35 pmRNSc£1.2m grant awarded
21st Sep 20232:39 pmRNSApplication for listing & total voting rights
11th Sep 20232:17 pmRNSBoard changes
6th Sep 20237:00 amRNSUKCA marking achieved for new CYP2C19 test
4th Aug 20234:00 pmRNSTotal Voting Rights
5th Jul 20239:11 amRNSEquity Prepayment Facility drawdown
16th Jun 20232:28 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSMulti-partner grant awarded
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SEC
Strategic Eqty
LSE
-1.59%
PCFT
Polar Cap Gbl
LSE
0.67%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
GEX
Georgina Energy
LSE
1.69%
PREM
Premier African Minerals
LSE
-16.00%
PANR
Pantheon Resources plc
LSE
31.07%
ALRT
Defence Holdings
LSE
0.00%